Enliven Therapeutics stock surges 28% on Merck-Terns deal
Go back to Enliven Therapeutics stock surges 28% on Merck-Terns deal| (NASDAQ: ELVN) | Delayed: 37.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.00 | 52 Week High | $ | |||
| Open | $37.00 | 52 Week Low | $ | |||
| Day High | $37.00 | P/E | N/A | |||
| Day Low | $37.00 | EPS | $ | |||
| Volume | 12,668 | |||||
| (NASDAQ: MAZE) | Delayed: 23.66 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.66 | 52 Week High | $ | |||
| Open | $23.66 | 52 Week Low | $ | |||
| Day High | $23.66 | P/E | N/A | |||
| Day Low | $23.66 | EPS | $ | |||
| Volume | 202 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 119.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $119.09 | 52 Week High | $65.46 | |||
| Open | $119.09 | 52 Week Low | $47.97 | |||
| Day High | $119.09 | P/E | 81.01 | |||
| Day Low | $119.09 | EPS | $1.47 | |||
| Volume | 1,646 | |||||

